Atlas Trials

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Clinical trial NCT03994783 · TERMINATED

Trial details

NCT number
NCT03994783
Sponsor
Imperial College London
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Kidney Transplant RejectionAntibody-mediated Rejection
Start date
2019-07-17
Primary completion
2021-07-17
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.